Académique Documents
Professionnel Documents
Culture Documents
Medication Administration
Vol. 17 Issue 2
February 2016
Page 2
Vol. 16 Issue 2
February 2016
DATE:
UNIT:
Directions: Place the letter of the one best answer in the space provided.
_____1. In 2015, more new drugs were approved by the FDA than in any year since 1996.
A. True
B. False
_____2. Unique drug approvals for 2015 include the first-ever:
A. opioid using a self-injector pen
B. 3-D printed drug
C. oral drug on a dissolvable film
D. medication for treatment of tardive dyskinesia
_____3. Which of the following women is at highest risk for adverse effects of Addyi (flibanserin):
A. Carol, who is premenopausal
B. Barbara, who has type 2 diabetes
C. Rachel, who had a hysterectomy 2 years ago
D. Gayle, who has 3-4 alcoholic drinks daily
_____4. A significant benefit of the new atypical antipsychotic drug, Aristada (aripiprazole laureate),
is that it is:
A. approved for use in dementia-related psychosis
B. safer than similar drugs, and does not cause effects such as weight gain or hypotension
C. long-acting and is administered monthly
D. available as a quick-dissolving oral tablet
_____5. Corlanor (ivabradine) and Entresto (sacubitril/valsartan) are new drugs approved to treat:
A. heart failure
B. hypertension
C. pulmonary hypertension
D. all of the above
_____6. Which of the following new drugs is most likely to cause bleeding as an adverse effect:
A. Cosentyx (secukinumab)
B. Bridion (sugammadex)
C. Praluent (alirocumab)
D. Kengreal (cangrelor)
_____7. Praxbind (idarucizumab) is a first-in-class drug approved to reverse the anticoagulant
effects of:
A. warfarin
B. apixaban
C. enoxaparin
D. dabigatran
_____8. Tresiba (insulin degludec) is a novel insulin that:
A. can be taken orally
B. is ultra-long acting
C. is approved for treatment of type 2 diabetes only
D. must be taken immediately prior to a meal
_____9. The nurse determines that treatment with Varubi (rolapitant) is effective when the patient
taking it states:
A. I dont feel like I have to run to the bathroom to urinate every hour.
B. Im having a soft, formed bowel movement every day.
C. I havent had any nausea or vomiting.
D. I dont have much of an appetite.
____10. Which of the following is an FDA program set up specifically to encourage the voluntary
reporting of serious adverse effects of medications or devices:
A. Center for Drug Evaluation and Research
B. Sentinel Events
C. MedWatch
D. Report NOW
Page 2
Unit
Test Date
Score
Additional Information:
Phone: (804) 233-3707
Fax:
(804) 233-3705
Email: editor@peakdev.com
1. Issue:
Month:
2. Facility Information
(provide information about the subscribing facility):
Facility Name: ________________________________
Address: ___________________________________
___________________________________
City: _________________ State: _____ Zip: _______
3. Applicant Information
(provide information about yourself)
Name: ___________________________________
Address: _________________________________
City: ________________ State: _____ Zip: ______
Daytime Phone Number:___________________
Nursing License #: ________________________
Licensing State: __________________________
Previous Peak Development Contact Hours: Yes
No
6. PAYMENT INFORMATION:
APPLICATIONS MUST INCLUDE PAYMENT
Cost: $10 per test nonrefundable
Check Payment method - Provide all information
_______ Check Payable to Peak Development Resources
($40.00 service fee for returned checks)
_______ Credit Card (circle one):
VISA
MASTERCARD
Credit Card Number: ____________________________
Credit Card Expiration Date: ___________
Print Name on Card: ____________________________
Authorized Signature: ___________________________
Billing Address for credit card:
Address: _______________ _____________________
____________________________________
State: ________ Zip: __________
7. EVALUATION
A. How long, in minutes, did it take you to complete
this educational packet? _______minutes.
B.
1.
2.
3.
4.
5.
6.
7.
8.
9.